Cypherpunk Technologies Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer.
$1.87-3.86%
报价 2026-11-13
市值
$201.5M
EV
$302.8M
PE (TTM)
4.9x
预期 PE (FY2026)
–
52 周区间距高点 -54.6%
$0.51$4.12
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
爆发潜力
2026-11-07不在筛选范围:industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| CYPHLeap Therapeutics, Inc. | $201.5M | -3.9% | – | 0% | 4.9x | – | – | |
| APLMApollomics, Inc. | $51.5M | +2.2% | +1230.0% | 100% | – | – | – | |
| BCTXBriaCell Therapeutics Corp. | $29.6M | -3.4% | – | 0% | – | – | – | |
| CTXRCitius Pharmaceuticals, Inc. | $14.7M | +0.5% | +83.7% | 20% | – | – | – | |
| DAREDaré Bioscience, Inc. | $9.8M | +2.0% | -62.5% | 30,089.1% | – | – | – | |
| PCSAProcessa Pharmaceuticals, Inc. | $5.2M | +1.1% | -32.9% | 0% | – | – | – | |
| ICUSeaStar Medical Holding Corporation | $2.4M | -20.2% | +90.0% | 92.6% | – | – | – | |
| ASBPAspire Biopharma Holdings, Inc. | $970,279 | +0.1% | – | 18.4% | – | – | – | |
| CRISCuris, Inc. | $867,750 | -22.2% | -84.3% | 99.3% | – | – | – | |
| 同行中位数 | – | – | +25.4% | 56.3% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。